by Ian Cooper

Some of the best opportunities can be found in beaten-down oversold stocks.

Especially when there’s still a good amount of fear.

Remember, crises often create opportunities, as we’ve learned from some of the richest investors.  Warren Buffett, for example, tells us to be “fearful when others are greedy, and greedy when others are fearful.” Sir John Templeton taught us to buy excessive pessimism.

Even Baron Rothschild once told investors, “The time to buy is when there’s blood in the streets, even if the blood is your own.”

Some of the top stocks you may want to consider are:

AbbVie (ABBV)

Over the last few weeks, ABBV plunged from about $215 to about $165, where it’s become oversold. It’s also over-extended on RSI, MACD and Williams’ %R. From its current price of $173, we’d like to see it rally back to $200 initially.

When momentum gets exhausted, this pattern pays out. To recognize the signs, click here.

Even better, while we wait for the recovery, we can collect its yield of 3.8%. Analysts at Guggenheim also reiterated a buy on the stock with a price target of $214.

Bristol Myers Squibb (BMY)

BMY recently plummeted from about $60 to $49, also become incredibly oversold.

From its last traded price of $49.23, we’d like to see BMY rally back to $60 initially. Helping, the US FDA just approved the company’s Opdivo plus Yervoy as a treatment for metastatic hepatocellular carcinoma (HCC).

Specifically, the FDA has greenlighted the use of the Opdivo plus Yervoy combination as a first-line option for adults with hepatocellular carcinoma whose cancer cannot be removed or has spread (unresectable or metastatic).

Enbridge (ENB)

With a yield of 6.15%, Enbridge (ENB) holds the second-longest natural gas pipeline in the U.S., North America’s longest crude oil pipeline, and a high-growth, renewable power generation business.

Helping, analysts at Citi just initiated a buy rating on the ENB stock, which believes the company is well-positioned to benefit from global energy demands. In addition, as noted by Investing.com, “The firm’s analysts emphasized that Enbridge has consistently exceeded global energy demand growth by 400 basis points, a trend they anticipate will persist.”